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Abstract
Background: A nested case-control study is an efficient design that can be embedded within an existing cohort
study or randomised trial. It has a number of advantages compared to the conventional case-control design, and
has the potential to answer important research questions using untapped prospectively collected data.
Methods: We demonstrate the utility of the matched nested case-control design by applying it to a secondary
analysis of the Abnormal Doppler Enteral Prescription Trial. We investigated the role of milk feed type and changes
in milk feed type in the development of necrotising enterocolitis in a group of 398 high risk growth-restricted
preterm infants.
Results: Using matching, we were able to generate a comparable sample of controls selected from the same
population as the cases. In contrast to the standard case-control design, exposure status was ascertained prior to
the outcome event occurring and the comparison between the cases and matched controls could be made at the
point at which the event occurred. This enabled us to reliably investigate the temporal relationship between feed
type and necrotising enterocolitis.
Conclusions: A matched nested case-control study can be used to identify credible associations in a secondary
analysis of clinical trial data where the exposure of interest was not randomised, and has several advantages over a
standard case-control design. This method offers the potential to make reliable inferences in scenarios where it
would be unethical or impractical to perform a randomised clinical trial.
Keywords: Preterm infants, Feeding, Neonatology, Statistical methods, Nested case-control, Matching, Randomised
controlled trial
Key messages
 A matched nested case-control design provides an
efficient way to investigate causal relationships using
untapped data from prospective cohort studies and
randomised controlled trials
 This method has several advantages over a standard
case-control design, particularly when studying
time-dependent exposures on rare outcomes
 It offers the potential to make reliable inferences in
scenarios where unethical or practical issues
preclude the use of a randomised controlled trial
Background
Randomised controlled trials (RCTs) are regarded as
the gold standard in evidence based medicine, due to
their prospective design and the minimisation of
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important sources of bias through the use of random-
isation, allocation concealment and blinding. However,
RCTs are not always appropriate due to ethical or
practical issues, particularly when investigating risk
factors for an outcome. If beliefs about the causal role
of a risk factor are already embedded within a clinical
community, based on concrete evidence or otherwise,
then it is not possible to conduct an RCT due to lack
of equipoise. It is often not feasible to randomise po-
tential risk factors, for example, if they are biological
or genetic or if there is a strong element of patient
preference involved. In such scenarios, the main alter-
native is to conduct an observational study; either a
prospective cohort study which can be complicated
and costly, or a retrospective case-control study with
methodological shortcomings.
The nested case-control study design employs
case-control methodology within an established pro-
spective cohort study [1]. It first emerged in the
1970–80s and was typically used when it was expen-
sive or difficult to obtain data on a particular expos-
ure for all members of the cohort; instead a subset
of controls would be selected at random [2]. This
method with the use of matching has been shown
to be an efficient design that can be used to provide
unbiased estimates of relative risk with considerable
cost savings [3–5]. Cases who develop the outcome
of interest at a given point in time are matched to a
random subset of members of the cohort who have
not experienced the outcome at that time. These
controls may develop the outcome later and become
a case themselves, and they may also act as a con-
trol for other cases [6, 7]. This approach has a
number of advantages compared to the standard
case-control design: (1) cases and controls are sam-
pled from the same population, (2) exposures are
measured prior to the outcome occurring, and (3)
cases can be matched to controls at the time (e.g.
age) of the outcome event.
More recently, the nested case-control design has
been used within RCTs to investigate the causative
role of risk factors in the development of trial out-
comes [8–10]. In this paper we investigate the utility
of the matched nested case-control design in a sec-
ondary analysis of the ADEPT: Abnormal Doppler
Enteral Prescription Trial (ISRCTN87351483) data, to
investigate the role of different types of milk feed
(and changes in types of milk feed) in the develop-
ment of necrotising enterocolitis. We illustrate the
use of this methodology and explore issues relating to
its implementation. We also discuss and appraise the
value of this methodology in answering similar chal-




ADEPT: Abnormal Doppler Enteral Prescription Trial
(ISRCTN87351483) was funded by Action Medical Re-
search (SP4006) and investigated whether early (24–48 h
after birth) or late (120–144 h after birth) introduction
of milk feeds was a risk factor for necrotising enterocoli-
tis (NEC) in a population of 404 infants born preterm
and growth-restricted, following abnormal antenatal
Doppler blood flow velocities [11]. Consent and ran-
domisation occurred in the first 2 days after birth. There
was no difference found in the incidence of NEC be-
tween the two groups, however there was interest in the
association between feed type (formula/fortifier or exclu-
sive mother/donor breast milk) and the development of
NEC. Breast milk is one of few factors believed to reduce
the risk of NEC that has been widely adopted into clin-
ical practice, despite a paucity of high quality population
based data [12, 13]. However, due to lack of equipoise it
would not be ethical or feasible to conduct a trial rando-
mising newborn infants to formula or breast milk.
With additional funding from Action Medical Re-
search (GN2506), the authors used a matched nested
case-control design to investigate the association be-
tween feed type and the development of severe NEC, de-
fined as Bell’s staging Stage II or III [14], using detailed
daily feed log data from the ADEPT trial. The feed type
and quantity of feed was recorded daily until an infant
had reached full feeds and had ceased parenteral nutri-
tion, or until 28 days after birth, whichever was longest.
Using this information, infants were classified according
to the following predefined exposures:
(1) Exposure to formula milk or fortifier in the first 14
days of life
(2) Exposure to formula milk or fortifier in the first 28
days of life
(3) Any prior exposure to formula milk or fortifier
(4) Change in feed type (between formula, fortifier or
breast milk) within the previous 7 days.
In the remainder of the methods section we discuss
the challenges of conducting this analysis and practical
issues encountered in applying the matched nested case-
control methodology. In the results section we present
data from different aspects of the analysis, to illustrate
the utility of this approach in answering the research
question.
Cohort time axis
For the main trial analysis, time of randomisation was
defined as time zero, which is the conventional approach
given that events occurring prior to randomisation can-
not be influenced by the intervention under
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investigation. However, for the nested case-control ana-
lysis, time zero was defined as day of delivery because
age in days was considered easier to interpret, and also it
was possible for an outcome event to occur prior to ran-
domisation. Infants were followed up until their exit
time, which was defined by the first occurrence of NEC,
death or the last daily feed log record.
Case definition
An infant was defined as a case at their first recorded in-
cidence of severe NEC, defined as Bell’s staging Stage II
or III [14]. Infants could only be included as a case once;
subsequent episodes of NEC in the same infant were not
counted. Once an infant had been identified as a case,
they could not be included in any future risk sets for
other cases, even if the NEC episode had been resolved.
Risk set definition
One of the major challenges was identifying an appropri-
ate risk set from which controls could be sampled, whilst
also allowing the analysis to incorporate the time
dependent feed log data and adjust for known con-
founders. A diagnosis of NEC has a crucial impact on
the subsequent feeding of an infant, therefore it was es-
sential that the analysis only included exposure to non-
breast milk feeds prior to the onset of NEC. A standard
case-control analysis would have produced misleading
results in this context, as infants would have been de-
fined as a cases if they had experienced NEC prior to the
end of the study period, regardless of the timing of the
event in relation to exposure to non-breast milk. Using a
matched nested case-control design allowed us to match
an infant with a diagnosis of NEC (case) at a given point
in time (days from delivery) to infants with similar char-
acteristics (with respect to other important confounding
factors), who had not experienced NEC at the failure
time of the case. Figure 1 is a schematic diagram of this
process. Each time an outcome event occurred (case), in-
fants that were still at risk were eligible to be selected as
a control (risk set). A matching algorithm was used to
select a sample of controls with similar characteristics
from this risk set. Infants selected as controls could go
on to become a case themselves, and could also be in-
cluded in the risk sets for other cases.
Selection of matching factors
An important consideration was the appropriate selec-
tion of matching factors as well as identifying the
optimum mechanism for matching. Sex, gestational age
and birth weight were considered to be clear candidates
for matching factors, as they are all associated with the
development NEC. Gestational age and birth weight in
particular are both likely to impact the infant’s feeding
and thus their exposure to non-breast milk feeds. Both
gestational age and birth weight were matched simultan-
eously, because of the strong collinearity between gesta-
tional age and birth weight, illustrated in Fig. 2. This was
achieved by minimising the Mahalanobis distance from
the case to prospective controls of the same sex [15].
That is, selecting the control closest in gestational age
and birth weight to the case while taking into account
the correlation between these characteristics.
Typically, treatment allocation would be incorporated
as a matching factor since in a secondary analysis it is a
nuisance factor imposed by the trial design, which
should be accounted for. However, in this example, the
Fig. 1 Schematic diagram illustrating the selection of controls from each risk set. Three days following delivery, an infant develops NEC. At this
point, there are 11 infants left in the risk set. Four controls with the closest matching are selected, including one infant that becomes a future
case on day 18
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ADEPT allocation is associated with likelihood of expos-
ure, since it directly influences the feeding regime. For
example, an infant randomised to receive early introduc-
tion of feeds is more likely to be exposed to non-breast
milk feeds in the first 14 days (44%) than an infant ran-
domised to late introduction of feeds (23%). The main
trial results also demonstrated no evidence of association
with the outcome (NEC) and therefore there was a con-
cern about the potential for overmatching. Overmatch-
ing is caused by inappropriate selection of matching
factors (i.e. factors which are not associated with the
outcome of interest), which may harm the statistical effi-
ciency of the analysis [16]. Therefore, we did not include
the ADEPT allocation as a matching factor, but we con-
duct an unadjusted and adjusted analysis by trial arm, to
examine its impact on the results.
Selection of controls
Another important consideration was the method
used to randomly select controls from each risk set
for each case. This can be performed with or with-
out replacement and including or excluding the case
in the risk set. We chose the recommended option
of sampling without replacement and excluding the
case from the risk set, which produces the optimal
unbiased estimate of relative risk, with greater statis-
tical efficiency [17, 18]. However, infants could be
included in multiple risk sets and be selected more
than once as a control. We also included future
cases of NEC as controls in earlier risk sets, as their
exclusion can also lead to biased estimates of relative
risk [19].
Number of controls
In standard case-control studies it has been shown
that there is little statistical efficiency gained from
having more than four matched controls relative to
each case [20, 21]. Using five controls is only 4%
more efficient than using four, therefore there is no
added benefit in using additional controls if a cost is
attached, for example taking extra biological samples
in a prospective cohort setting. However gains in stat-
istical efficiency are possible by using more than four
controls if the probability of exposure among controls
is low (< 0.1) [4, 5]. Neither of these were issues for
this particular analysis, as there were no additional
costs involved in using more controls and prevalence
of the defined exposures to non-breast milk was over
20% among infants without a diagnosis of NEC. How-
ever, there was a concern that including additional
controls with increasing distance from the gestational
age and birth weight of the case may undermine the
matching algorithm. Also, increasing the number of
controls sampled per case would lead to an increase
in repeated sampling, resulting in larger number of
duplicates present in the overall matched control
population. This was a particular concern as control
duplication was most likely to occur for infants with
the lowest birth weight and gestational ages, from
which there is a much smaller pool of control infants
to sample from. This would have resulted in a small
number of infants (with low birth weight and gesta-
tional age) being sampled multiple times and having
disproportionate weighting in the matched control
sample. Therefore, we limited the number of matched
controls to four per case.
Fig. 2 Scatterplot of birth weight versus gestational age for infants with NEC (cases) and those without (controls)
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Statistical analysis
The baseline characteristics of infants with NEC, the
matched control group, and all infants with no diagnosis
of NEC (non-cases) were compared. Numbers (with per-
centages) were presented for binary and categorical vari-
ables, and means (and standard deviations) or medians
(with interquartile range and/or range) for continuous
variables. Cases were matched to four controls with the
same sex and smallest Mahalanobis distance based on
gestational age and birth weight. Conditional logistic re-
gression was used to calculate the odds ratio of develop-
ing NEC for cases compared matched controls for each
predefined exposure with 95% confidence intervals. Un-
adjusted odds ratios were calculated, along with esti-
mates adjusting for ADEPT allocation.
Results
The results of the full analysis, including the application
of this method to explore the relationship between feed
type and other clinically relevant outcomes, are reported
in a separate clinical paper (in preparation). Of the 404
infants randomised to ADEPT, 398 were included in this
analysis (1 infant was randomised in error, 1 set of par-
ents withdrew consent, 3 infants had no daily feed log
data and for 1 infant the severity of NEC was unknown).
There were 35 cases of severe NEC and 363 infants
without a diagnosis of severe NEC (non-cases). Of the
140 matched controls randomly sampled from the risk
set, 109 were unique, 31 were sampled more than once,
and 8 had a subsequent diagnosis of severe NEC.
The baseline characteristics of infants with severe NEC
(cases) and their matched controls are shown in Table 1,
alongside the characteristics of infants without a diagno-
sis of severe NEC (non-cases). The matching algorithm
successfully produced a well matched collection of con-
trols, based on the majority of these characteristics.
There were, however, a slightly higher proportion of in-
fants with the lowest birthweights (< 750 g) among the
cases compared to the matched controls (49% vs 38%).
The only other factors to show a noticeable difference
between cases and matched controls are maternal hyper-
tension (37% vs 49%) and ventilation at trial entry (6% vs
21%), neither of which have been previously identified as
risk factors for NEC. Figure 3 shows scatter plots of
birth weight and gestational age for the 35 individual
cases of NEC and their matched controls, which pro-
vides a visual representation of the matching.
The main results of the adjusted analysis are presented
in Fig. 4. Unadjusted analyses are included in Table A1
in the supplementary material, alongside a post-hoc sen-
sitivity analysis that additionally includes covariate ad-
justment for gestational age and birthweight. While the
study did not identify any significant trends between
feed-type and severe NEC the findings were consistent
Table 1 Baseline characteristics of cases and matched controls










Allocated to early arm, n (%) 17 (48.6) 74 (52.9) 182 (50.1)
Male sex, n (%) 20 (57.1) 80 (57.1) 193 (53.2)
Gestational age (weeks)




32 (29 to 33)
< 29 weeks 16 (45.7) 61 (43.6) 69 (19.0)
> =29 weeks 19 (54.3) 79 (56.4) 294 (81.0)
Birth weight (grams)






< 750 g 17 (48.6) 53 (37.9) 57 (15.7)
> =750 g 18 (51.4) 87 (62.1) 306 (84.3)
Multiple pregnancy, n (%)
Twins 5 (14.3) 26 (18.6) 83 (22.9)
Triplets 0 3 (2.1) 6 (1.7)
Pregnancy induced
hypertension, n (%)
13 (37.1) 69 (49.3) 145 (40.1)
Missing 0 0 1
Absent/reversed doppler
abnormality, n(%)
35 (100.0) 138 (98.6) 347 (95.6)
Given antenatal steroids, n
(%)
34 (97.1) 132 (95.7) 331 (91.4)
Missing 0 2 1
Onset of delivery, n (%)
Spontaneous 2 (5.7) 2 (1.4) 7 (1.9)
Induced 0 1 (0.7) 4 (1.1)
Caesarean 33 (94.3) 137 (97.9) 352 (97.0)
Apgar score at 5 min
Median (IQR) 9 (8 to 9) 9 (8 to 10) 9 (9 to 10)
Missing 2 2 7
Ventilated at trial entry, n (%) 2 (5.7) 30 (21.4) 45 (12.4)
CPAPb at trial entry, n (%) 22 (62.9) 78 (55.7) 122 (33.6)
UACc in situ at trial entry, n
(%)
11 (31.4) 35 (25.0) 44 (12.1)
UVCd in situ at trial entry, n
(%)
19 (54.3) 67 (48.6) 92 (25.4)
Missing 0 2 1
Any diagnosis of severe NECe 35 (100.0) 8 (5.7) 0
a109 unique controls. Each case is matched to 4 controls with the same sex
and the smallest distance in terms of the Mahalanobis distance based on
gestational age and birth weight. For cases where the difference is the same,
infants are selected at random. bContinuous Positive Airway Pressure.
cUmbilical artery catheter. dUmbilical venous catheter. eMatched controls can
include infants who develop severe necrotising enterocolitis at some time in
the future
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with the a priori hypothesis, that exposure to non-breast
milk feeds is associated with an increased risk of NEC.
In addition, the study identified some potential trends in
the association of feed-type with other important out-
comes, worthy of further investigation.
Discussion
Employing a matched nested case-control design for this
secondary analysis of clinical trial data overcame many
of the limitations of a standard case-control analysis. We
were able to select controls from the same population as
the cases thus avoiding selection bias. Using matching,
we were able to create a comparable sample of controls
with respect to important clinical characteristics and
confounding factors. This method allowed us to reliably
investigate the temporal relationship between feed type
and severe NEC since the exposure data was collected
prospectively prior to the outcome occurring. We were
also able to successfully investigate the relationship be-
tween feed type and several other important outcomes
such as sepsis. A standard case-control analysis is typic-
ally based on recall or retrospective data collection once
the outcome is known, which can introduce recall bias.
If we had performed a simple comparison between cases
Fig. 3 Scatterplots showing the matched cases and controls for each case of severe NEC. Each panel contains a separate case of NEC and the
matched controls
Fig. 4 Forest plot showing the adjusted odds ratio comparing severe NEC to exposures. Odds ratios are adjusted for sex, gestational age and
birthweight (via matching) and trial arm (via covariate adjustment). aOdds ratio and 95% confidence interval. b109 unique controls
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and non-cases of NEC without taking into account the
timing of the exposure, this would have produced mis-
leading results. Another advantage of the matched
nested case-control design was that we were able to
match cases to controls at the time of the outcome event
so that they were of comparable ages. The methodology
is especially powerful when the timing of the exposure is
of importance, particularly for time-dependent expo-
sures such as the one studied here.
While the efficient use of existing trial data has a num-
ber of benefits, there are of course disadvantages to
using data that were collected for another primary pur-
pose. For instance, it is possible that such data are less
robustly collected and checked. As a result, researchers
may be more likely to encounter participants with either
invalid or missing data.
For instance, the some of the additional feed log data
collected in ADEPT were never intended to be used to
answer clinical research questions, rather, their purpose
was to monitor the adherence of participants to the
intervention or provide added background information.
In this study, it was necessary to make assumptions
about missing data to fill small gaps in the daily feed
logs. Researchers should take care that such assumptions
are fully documented in the statistical analysis plan in
advance and determined blinded to the outcome. An-
other option is to plan these sub-studies at the design
phase, however, there needs to be a balance between the
potential burden of additional data collection and having
a streamlined trial that is able to answer the primary re-
search question.
Another limitation of the methodology is that it is only
possible to match on known confounders. This is in
contrast to a randomised controlled trial, in which it is
possible to balance on unknown and unmeasured base-
line characteristics. As a consequence, particular care
must be given to select important matching factors, but
also to avoid overmatching.
The methodology allows for participants to be selected
as controls multiple times, so there is the possibility that
systematic duplication of a specific subset of participants
(e.g. infants with a lower birthweight and smaller gesta-
tional age) could lead to a small number of participants
disproportionately influencing the results. Within this
study, we conducted sensitivity analyses with fewer con-
trols, and were able to demonstrate that this had a min-
imal impact on the findings.
Conclusions
We have demonstrated how a matched nested case-
control design can be embedded within an RCT to
identify credible associations in a secondary analysis
of clinical trial data where the exposure of interest
was not randomised. We planned this study after the
clinical trial data had already been collected, but it
could have been built in seamlessly as a SWAT
(Study Within A Trial) during the trial design phase,
to ensure that all relevant data were collected in ad-
vance with minimal effort. This method has several
advantages over a standard case-control design and
offers the potential to make reliable inferences in sce-
narios where unethical or practical issues preclude
the use of an RCT. Moreover, because of the flexibil-
ity of the methodology in terms of the design and
analysis, the matched nested case-control design could
reasonably be applied to a wide range of challenging
research questions. There is an abundance of high
quality large prospective studies and clinical trials
with well characterised cohorts, in which this meth-
odology could be applied to investigate causal rela-
tionships, adding considerable value for money to the
original studies.
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